Le groupe L’Oréal vient de signer un accord en vue de l’acquisition Skinbetter Science, an American skin care brand prescribed by health professionals.
Skinbetter Science was founded in 2016 by Jonah Shacknai, Justin Smith and Seth Rodner, professionals in the pharmaceutical industry. The brand has since known one of the most fortes croissances in this circuit in the United States. It is recognized for the effectiveness of its patented ingredients as well as the ultra sensoriality and richness of its textures.
” Réputée pour ses innovantes formulations, Skinbetter Science, integré des actifs de pointe destinés aussi bien aux soins anti-age, hydratants, nettoyants et exfoliants, qu’à la protection solaire et aux peelings. Based on deep knowledge in dermatology and chemistry, these innovative formulations are supported by clinical trials conducted by professional members of the American Board of Dermatology. “, explains L’Oréal in a press release.
Dermatologists and surgeons
Skinbetter Science products are essentially prescribed by a network of dermatologists, plastic surgeons and aesthetic doctors in the United States and distributed by a medical team distributed throughout the territory.
Skinbetter Science a realized a figure of over 95 million dollars sur douze mois glissants au 31 juillet 2022. The current management team will continue to manage the activity, depuis le siège social installed in Arizona, under the supervision of Christina FairPresident of the Active Cosmetics Division of L’Oréal USA.
Pour: Myriam Cohen-Welgrynpresident of the Division Cosmétique Active du groupe L’Oréal, ” The acquisition of Skinbetter Science will perfectly complement the portfolio of the Cosmétique Active Division and contribute strongly to the mission that is ours since then. improve health and beauty thanks to science and innovation. I am convinced that this American brand with strong growth offers immense potential on the international level “.
David Greenberg, directeur général de L’Oréal USA et president de la zone Amérique du Nord, added: ” I am certain that the brand will reinforce our presence on the North American market of dermocosmetics, an activity that presents a strong potential for growth. For Christina Fair, our Division Cosmétique Active and myself, this acquisition offers the opportunity to take advantage of the expertise of the fantastic team that gave birth to this brand and to consolidate the relationship of trust that it has woven. with its partners of the medical world, in order to strengthen even more our part of the market in this profession “.
This acquisition should be finalized at the beginning of the fourth quarter of 2022, subject to usual regulatory approvals and other closing conditions.